L. Thompson

发表

Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial.

M. Parmar, P. Quirke, J. Allan, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant Short-Course Radiotherapy for Upper Third Rectal Tumors: Systematic Review and Individual Patient Data Metaanalysis of Randomized Controlled Trials

E. Kranenbarg, D. Sebag‐Montefiore, J. Burke, 2021, Annals of Surgical Oncology.

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial

J. Monson, M. Parmar, R. Stephens, 2009, The Lancet.

Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial.

R. Stephens, P. Quirke, G. Griffiths, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy dose reductions in obese patients with colorectal cancer.

R. Stephens, P. Chambers, L. Thompson, 2012 .

Chemotherapy dose reductions in obese patients with colorectal cancer.

R. Stephens, P. Chambers, L. Thompson, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ) adenocarcinoma.

D. Smith, D. Cunningham, W. Allum, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised trial of Procarbazine, CCNU and Vincristine (PCV) vs Temozolomide (5-day or 21-day schedule) for recurrent high grade glioma (MRC BR12, ISRCTN83176944).

M. Brada, R. Gabe, S. Stenning, 2008 .

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

Richard J Stephens, Mahesh KB Parmar, M. Parmar, 2007, The Lancet.

Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

D. Pearson, K. Ichimura, M. Brada, 2014, Acta neuropathologica communications.

Prognostic and predictive markers in recurrent high grade glioma ; results from the BR 12 randomised trial

D. Pearson, K. Ichimura, M. Brada, 2014 .

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

D. Kerr, J. Pignon, A. González-Neira, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

K. Hopkins, S. Lee, D. Levy, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

J. Monson, M. Parmar, R. Stephens, 2009, The Lancet.

Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials.

J. Reis-Filho, D. Smith, M. Band, 2013, European journal of cancer.

Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

D. Pearson, K. Ichimura, M. Brada, 2014, Acta Neuropathologica Communications.

Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report.

D. Smith, D. Cunningham, W. Allum, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

The Impact of Short Course Pre-operative Radiotherapy on Patients' Quality of Life: Data from the MRC CR07/NCIC CO16 Randomised Clinical Trial in Patients with Rectal Cancer

R. Stephens, R. Steele, P. Quirke, 2008 .

Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial.

J. Monson, R. Stephens, P. Quirke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial.

J. Reis-Filho, A. Wotherspoon, D. Cunningham, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

American Society of Clinical Oncology guideline on weight-based dosing and its impact on trial design.

R. Stephens, P. Chambers, L. Thompson, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

M. Parmar, H. Wasan, G. Middleton, 2011, The Lancet.

Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer (FOCUS).

M. Parmar, P. Quirke, J. Allan, 2006, Journal of Clinical Oncology.

Capecitabine (Cap) and oxaliplatin (Ox) in elderly and/or frail patients with metastatic colorectal cancer: The FOCUS2 trial

H. Wasan, T. Maughan, R. Langley, 2007 .

Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial.

J. Monson, R. Stephens, P. Quirke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial.

J. Reis-Filho, A. Wotherspoon, R. Wong, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

D. Kerr, J. Pignon, A. González-Neira, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

OC-0219 THE MRC CR07 TRIAL NCIC CO16 TRIAL AFTER A MEDIAN FOLLOW UP OF 8 YEARS

J. Monson, P. Quirke, D. Sebag‐Montefiore, 2012 .

A Randomized Controlled Trial of Metronidazole Vaginal Cream in the Treatment of Papanicolaou Smears Showing Atypical Squamous Cells of Undetermined Significance (ASCUS)

R. Gibbs, L. Thompson, L. Thompson, 2001, Journal of lower genital tract disease.